Neuronetics investor reports 15.17% ownership stake

Neuronetics, Inc. investor Jorey Chernett reports a 15.17% ownership stake in the company’s common stock.

Rhea-AI Filing Summary

Neuronetics, Inc. investor Jorey Chernett reports a 15.17% ownership stake in the company’s common stock. As of the close of business on May 26, 2026, he beneficially owned 10,553,988 shares, based on 69,587,840 shares outstanding as of May 1, 2026.

The filing states that these shares were purchased with personal funds for an aggregate price of approximately $20,619,936. Chernett holds sole voting and sole dispositive power over all reported shares, with no shared voting or dispositive authority. An exhibit lists individual share transactions since the prior amendment.

Insights

Equity ownership & governance analyst

Investor reports a sizable, 15.17% sole-controlled stake in Neuronetics.

Jorey Chernett discloses beneficial ownership of 10,553,988 shares of Neuronetics common stock, representing approximately 15.17% of outstanding shares as of May 1, 2026. The stake was acquired using personal funds totaling about $20,619,936, indicating a meaningful financial commitment.

The filing notes sole voting and sole dispositive power over all reported shares, which concentrates decision-making for this block with one holder. No other party is identified as sharing rights to dividends or sale proceeds. The attached exhibit of recent trades may help contextualize how the position evolved since the last amendment.

Key Figures

Beneficial ownership: 10,553,988 shares Ownership percentage: 15.17% Shares outstanding: 69,587,840 shares +4 more

7 metrics

Beneficial ownership 10,553,988 shares Shares beneficially owned by Jorey Chernett as of May 26, 2026

Ownership percentage 15.17% Portion of Neuronetics common stock beneficially owned

Shares outstanding 69,587,840 shares Neuronetics shares outstanding as of May 1, 2026

Aggregate purchase price $20,619,936 Approximate total personal funds used to purchase reported shares

Sole voting power 10,553,988 shares Shares over which Chernett has sole power to vote

Sole dispositive power 10,553,988 shares Shares over which Chernett has sole power to dispose

Event date May 19, 2026 Date of event triggering the amended Schedule 13D filing

Key Terms

beneficially owned, Sole Voting Power, Sole Dispositive Power, Schedule 13D, +1 more

5 terms

beneficially owned financial

"As of the close of business on May 26, 2026, the Reporting Person beneficially owned 10,553,988 Shares."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Number of Shares Beneficially Owned by Each Reporting Person With: 7 | Sole Voting Power 10,553,988.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"9 | Sole Dispositive Power 10,553,988.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13D regulatory

"This Amendment No. 2 to ("Amendment No. 2") amends and supplements the initially filed by the Reporting Person on March 31, 2026"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

Percent of class financial

"13Percent of class represented by amount in Row (11) 15.17 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Neuronetics (STIM) shares does Jorey Chernett beneficially own?

Jorey Chernett beneficially owns 10,553,988 shares of Neuronetics common stock. This figure is reported as of the close of business on May 26, 2026, and reflects his direct economic and voting interest in the company’s shares as disclosed in the Schedule 13D/A.

What percentage of Neuronetics (STIM) does Jorey Chernett’s stake represent?

Chernett’s 10,553,988 shares represent approximately 15.17% of Neuronetics’ outstanding common stock. This percentage is calculated using 69,587,840 shares outstanding as of May 1, 2026, as reported in Neuronetics’ Form 10-Q filed with the SEC on May 5, 2026.

How much did Jorey Chernett pay for his Neuronetics (STIM) shares?

The filing states that Chernett acquired his 10,553,988 Neuronetics shares using personal funds for an aggregate purchase price of approximately $20,619,936. This total reflects the combined cost of the reported holdings rather than any single transaction price or recent trade level.

Does anyone share voting or dispositive power over Jorey Chernett’s Neuronetics (STIM) shares?

No shared authority is reported. The filing shows Chernett has sole power to vote or direct the vote over 10,553,988 shares and sole power to dispose or direct the disposition of the same amount, with shared voting and dispositive power each reported as zero.

On what share count is Jorey Chernett’s 15.17% Neuronetics (STIM) ownership based?

The 15.17% ownership figure is based on 69,587,840 Neuronetics common shares outstanding as of May 1, 2026. That outstanding share number comes from Neuronetics’ Quarterly Report on Form 10-Q filed with the SEC on May 5, 2026, and is referenced in the Schedule 13D/A.

What type of SEC filing did Jorey Chernett submit for his Neuronetics (STIM) stake?

Chernett submitted an Amendment No. 2 to a Schedule 13D relating to Neuronetics common stock. The amendment updates his beneficial ownership information and supplements a prior Schedule 13D filing made on March 31, 2026, with additional details on share count, percentage, and recent transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 10:33 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)

Neuronetics, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

64131A105

(CUSIP Number)

Jorey Chernett
6222 Indianwood Tr.,
Bloomfield Hills, MI, 48301
(248) 469-8811

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

05/19/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 64131A105

1

Name of reporting person

Chernett Jorey

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 10,553,988.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 10,553,988.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

10,553,988.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

15.17 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.01 par value
(b)	Name of Issuer: Neuronetics, Inc.
(c)	Address of Issuer's Principal Executive Offices: 3222 PHOENIXVILLE PIKE, MALVERN, PENNSYLVANIA , 19355.
Item 1 Comment: This Amendment No. 2 to Schedule 13D ("Amendment No. 2") amends and supplements the Schedule 13D initially filed by the Reporting Person on March 31, 2026 (the "Original Schedule 13D") with respect to the Shares. Except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Schedule 13D.
Item 3.	Source and Amount of Funds or Other Consideration
	The 10,553,988 Shares held by Mr. Chernett were purchased with personal funds for an aggregate purchase price of approximately $20,619,936.
Item 5.	Interest in Securities of the Issuer
(a)	The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 69,587,840 Shares outstanding as of May 1, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on May 5, 2026. As of the close of business on May 26, 2026, the Reporting Person beneficially owned 10,553,988 Shares. Percentage: Approximately 15.17%
(b)	1. Sole power to vote or direct vote: 10,553,988 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 10,553,988 4. Shared power to dispose or direct the disposition: 0
(c)	The transactions in the Shares by the Reporting Person since the filing of Amendment No. 1 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.
(d)	No person other than the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
(e)	Not applicable.
Item 7.	Material to be Filed as Exhibits.
	Exhibit 1 - Transactions in the Securities

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/ Jorey Chernett
Name/Title:	Jorey Chernett
Date:	05/27/2026